All the benefits of molecular testing
in an affordable and easy-to-use system.
Using next-generation technology, and a customer-centric business model, Great Basin is making fast and accurate molecular diagnostics possible for every hospital and lab.
Seethru Equity updated their report of Great Basin following the FDA clearance of the company’s Stool […]View Link
At clearance, Company has nearly $2.0 million of potential annual revenue in active or scheduled evaluation […]View Post View/Download PDF
New Business Pipeline exceeds $5.0 million in potential new revenue; Nearly $2.0 million in potential pipeline […]View Post View/Download PDF